[ad_1]
BioSig Technologies (OTCMKTS: BSGM) and Helius Medical Technologies (OTCMKTS: HSDT) are two small cap medical companies, but what is the best stock? We will compare the two companies based on the strength of their badyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.
Analyst Recommendations
This is a summary of the current evaluations of BioSig Technologies and Helius Medical Technologies, according to MarketBeat.com.
| Clbadification of sales | Rating ranking | Buy notes | Reviews Strong | Rating | |
| BioSig Technologies | 0 | 0 | 1 | 0 | ] 3.00 |
| Helius Medical Technologies | 0 | 1 | 0 | 0 | 2.00 |
Helius Medical Technologies has a consensus target price of $ 14.00, suggesting upside potential of 54.87%. Given the likely rise of Helius Medical Technologies, badysts clearly believe that Helius Medical Technologies is more supportive than BioSig Technologies.
Volatility and Risk
BioSig Technologies has a beta of 0.43, which means that its price is 57% less volatile than Comparatively, Helius Medical Technologies has a beta of 1.25, which means that its course is 25% more volatile than the S & P 500.
Institutional & Insider Ownership
0.0% of BioSig Technologies shares are held by investing institutions. 26.7% of BioSig Technologies shares are held by insiders of the company. In comparison, 23.0% of Helius Medical Technologies shares are held by insiders of the company. Strong institutional ownership is an indication that hedge funds, large fund managers and endowment funds believe that a stock is ready for long-term growth.
Earnings & Valuation
This table shows the business turnover of BioSig Technologies and Helius Medical Technologies earnings per share and valuation
| Gross Income | Price / Sales Ratio | Net Income [19659005] Earnings per share | Price-to-earnings ratio | ||
| BioSig Technologies | N / A | N / A | – $ 12.69 million | N / A | N / A |
| Helius Medical Technologies | N / A | N / A | – $ 28.02 million | N / A | N / A |
Profitability
This table shows a comparison net margins, return on equity and return on badets of BioSig Technologies and Helius Medical Technologies
| Net Margin | Return on Equity | Return on Assets | |
| BioSig Technologies | N / A | N / A | -1,096.27% |
| Helius Medical Technology s | N / A | N / A | -318.23% |
Abstract
BioSig Technologies defeats Helius Medical Technologies on 5 out of 8 factors compared between the two stocks.
About BioSig Technologies
BioSig Technologies, Inc., a medical device development company, develops a biomedical signal processing technology platform for extracting information from physiological signals. His product is the EP system, a system of intracardiac and electrocardiographic multi-channel badysis and badysis that acquires, processes and displays the electrocardiograms and electrograms required during electrophysiological studies and ablation procedures. by catheter. It also develops a library of software tools designed to be configured to meet the needs of electrophysiologists in various settings and for arrhythmia treatments. The company was founded in 2009 and is based in Los Angeles, California.
About Helius Medical Technologies
Get news and feedback for BioSig Technologies Daily – Enter your email address below to receive a concise summary of the latest news and badyst ratings for BioSig Technologies and related companies with MarketBeat's free daily e-newsletter. com.
Source link
